![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
Under the agreement, Taiwan Toyo will distribute the new anti-cancer drug Yondelis (trabectedin), a newly synthesized anti-tumor drug derived from the sea squirt Ecteinascidia turbinata, in Taiwan, Hong Kong and Macau.
Lead Product(s): Trabectedin
Therapeutic Area: Oncology Product Name: Yondelis
Highest Development Status: ApprovedProduct Type: Small molecule
Recipient: PharmaMar
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Licensing Agreement June 09, 2020